Evidence map›Paper›PMID 41877252›Full record

ArticleAlzheimer's research & therapy2026

Diffusion tensor imaging analysis along the perivascular space suggests impaired glymphatic clearance in Lewy body dementia subtypes.

Naomi Hannaway, Angeliki Zarkali, Rohan Bhome, Ivelina Dobreva, Sabrina Kalam, George E C Thomas, Barbara Dymerska, Irene Gorostiaga Belio, Katie Tucker, Amanda Heslegrave and 2 more

Abstract read
In one paragraph

Article in Alzheimer's research & therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Naomi HannawayDementia Research Centre, UCL Institute of Neurology, 10-12 Russell Square House, London, WC1B 5EH, UK. n.hannaway@ucl.ac.uk.
Angeliki ZarkaliDementia Research Centre, UCL Institute of Neurology, 10-12 Russell Square House, London, WC1B 5EH, UK.
Rohan BhomeDementia Research Centre, UCL Institute of Neurology, 10-12 Russell Square House, London, WC1B 5EH, UK.
Ivelina DobrevaDementia Research Centre, UCL Institute of Neurology, 10-12 Russell Square House, London, WC1B 5EH, UK.
Sabrina KalamDementia Research Centre, UCL Institute of Neurology, 10-12 Russell Square House, London, WC1B 5EH, UK.
George E C ThomasDementia Research Centre, UCL Institute of Neurology, 10-12 Russell Square House, London, WC1B 5EH, UK.
Barbara DymerskaDepartment of Imaging Neuroscience, UCL, 12 Queen Square, London, WC1N 3AR, UK.
Irene Gorostiaga BelioDementia Research Centre, UCL Institute of Neurology, 10-12 Russell Square House, London, WC1B 5EH, UK.
Katie TuckerDementia Research Centre, UCL Institute of Neurology, 10-12 Russell Square House, London, WC1B 5EH, UK.
Amanda HeslegraveUnited Kingdom Dementia Research Institute at University College London, London, WC1E 6BT, UK.
Henrik ZetterbergUnited Kingdom Dementia Research Institute at University College London, London, WC1E 6BT, UK.
Rimona S WeilDementia Research Centre, UCL Institute of Neurology, 10-12 Russell Square House, London, WC1B 5EH, UK.

Funding

Alzheimer's Research UK 2018B-001Wellcome TrustWellcome Trust 225263Z/22/ZWellcome Trust 226793/Z/22/Z
6 · The paper itself

Abstract

backgroundParkinson’s disease dementia (PDD) and dementia with Lewy bodies (DLB) are subtypes of Lewy body dementia (LBD) and overlap in symptoms and pathology. Glymphatic function is implicated in LBD pathophysiology due to reduced clearance of abnormal proteins. We aimed to investigate differences in diffusion tensor imaging along the perivascular space (DTI-ALPS), a candidate in vivo measure of glymphatic function, between LBD sub-types. We compared DTI-ALPS between DLB, PDD, Parkinson’s with normal cognition (PD-NC), and control participants.

methodsWe recruited participants with DLB, PDD, PD-NC, and controls from neurology clinics and patient support groups. Participants were aged 50–80, clinically diagnosed. Exclusions were confounding neurological or psychiatric conditions or metal precluding MRI scanning. Participants underwent MRI brain, plasma sampling and clinical and cognitive assessments. DTI-ALPS was calculated for each participant. As DTI-ALPS can be influenced by white matter distribution, we also calculated a metric called “complexity”. We tested group differences in DTI-ALPS, and associations with clinical variables across all patient groups including cognition, motor scores, sleep and fluctuations.

resultsFifty-one DLB (43 M, 72.7 ± 5.5 years), 35 PDD (25 M, 69.5 ± 7.8 years), 60 PD-NC (27 M, 63.1 ± 7.33 years), and 26 controls (13 M, 66.7 ± 9.28 years), were included for analysis. DTI-ALPS significantly differed between groups (F(3, 165) = 22.68, p<.0001), controlling for age and sex. DTI-ALPS did not differ between PD-NC and controls, whilst cognitively impaired groups (PDD, DLB) had reduced DTI-ALPS relative to PD-NC and to controls(pFDR<0.05). DTI-ALPS was further reduced in DLB relative to PDD. These findings held when corrected for complexity, which accounts for differences in white matter distribution (F(3, 161) = 28.11, p<.0001). Finally, DTI-ALPS correlated with cognition, controlling for age, (MOCA: β = 4.57, p=.002; MMSE: β = 2.95, p=.029), but this association did not survive further correction for sex and complexity.

conclusionsWe showed that DTI-ALPS, is reduced in LBD compared to PD-NC and controls; and is further reduced in DLB compared to PDD. DTI-ALPS is an easily-extracted metric from widely-used MRI scans. It has potential to be translated and automated for use in clinical pipelines, and could be used in combination with other biomarkers, to identify LBD patients with a more aggressive disease course in clinical trials and in the clinical setting.

Indexed as

BrainDiffusion Tensor ImagingGlymphatic SystemLewy Body DiseaseParkinson DiseaseAgedAged, 80 and overFemaleHumansMaleMiddle AgedNeuropsychological Tests

Identifiers

PMID41877252
PMCPMC13137496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.